GUANGZHOU, Chine, 3 mai 2026 /PRNewswire/ — La 139e Foire chinoise des importations et des exportations…
Blog
Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio
– FORZINITY™ (elamipretide) injection early commercial momentum demonstrates strong patient uptake and rapid access timelines –…
Altesa BioSciences Selected for Oral Presentation at the American Thoracic Society 2026 International Congress
Presentation details the impact of vapendavir on quality of life and lung function ATLANTA, April 30,…
Are You All In? Target ALS Goes "All In For ALS Awareness" with Campaign to Highlight the Community and Research Building a World Where Everyone Lives
NEW YORK, April 30, 2026 /PRNewswire/ — For ALS Awareness Month this May, Target ALS is…
Renibus Therapeutics Announces Oral Presentation on Phase 3 PROTECT Trial Data for RBT-1 at the American Association for Thoracic Surgery (AATS) Annual Meeting
Clinical study in cardiac surgery patients demonstrates favorable safety profile; exploratory analyses suggest potential benefit in…
Halozyme Appoints Darren Snellgrove as Chief Financial Officer
SAN DIEGO, April 30, 2026 /PRNewswire/ –Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme” or the “Company”) today…
Claros Demonstrates ≥99.99% PFAS Destruction in Groundwater from MPCA Lake Elmo Site
ClarosTechUV™ delivers commercial-scale performance in complex remediation conditions using PFAS concentrate from Lake Elmo Minnesota site…
Spring Health Named to TIME’s List of the TIME100 Most Influential Companies of 2026
The lifelong mental health platform also named one of TIME’s 10 Most Influential Wellness Companies of…
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS’ INNOVATIVE DIGITAL TOOL TO STREAMLINE PREAPPROVALS DOUBLES IN USE IN A YEAR
Tool removes the need for faxes and phone calls and is being utilized ~15,000 times a…
Journalists Share Latest on Baby Formula Safety, Estrogen Patches, and Postcancer Costs – KFF Health News
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the results of the FDA’s largest…